![Barry A. Labinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry A. Labinger
President at
CHECKMATE PHARMACEUTICALS, INC.
Profile
Barry A. Labinger is currently Chief Executive Officer at Flashpoint Therapeutics, Inc. since 2025, Chief Executive Officer at Gilboa Therapeutics Ltd. since 2022, and President at Checkmate Pharmaceuticals, Inc. Formerly, Mr. Labinger was President, Chief Executive Officer & Director at Checkmate Pharmaceuticals, Inc. from 2018 to 2021; President & Chief Executive Officer at Biothera Pharmaceuticals, Inc. (Delaware) from 2015 to 2018; Senior Director-Diabetes Marketing at Bristol Myers Squibb Co. from 1997 to 2000; Director at Anadys Pharmaceuticals, Inc. in 2011; President, Chief Executive Director & Director at Biothera, Inc.; SVP, VP-Marketing & GM-Commercial Operations at Immunex Corp.
from 2000 to 2002; Divisional Vice President at 3M Co. from 2002 to 2005; Chief Commercial Officer & Executive VP at Human Genome Sciences, Inc. from 2010 to 2012; and Executive VP & President-Biosciences Division at Emergent BioSolutions, Inc. from 2013 to 2016.
Education includes undergraduate studies at Northwestern University and an MBA from Kellogg School of Management.
Barry A. Labinger active positions
| Companies | Position | Start |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | President | - |
Gilboa Therapeutics Ltd.
 Gilboa Therapeutics Ltd. BiotechnologyHealth Technology Develops novel cell therapies for cancer | Chief Executive Officer | 01/05/2022 |
Former positions of Barry A. Labinger
| Companies | Position | End |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Chief Executive Officer | 27/10/2021 |
Biothera Pharmaceuticals, Inc. (Delaware)
 Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Chief Executive Officer | 01/12/2018 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 04/01/2016 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Director of Finance/CFO | 23/03/2010 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Director/Board Member | 23/11/2011 |
Training of Barry A. Labinger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Manufactures, markets, and researches therapeutic products | Health Technology |
3M Co.
 3M Co. Industrial ConglomeratesProducer Manufacturing Manufactures personal safety, industrial adhesives, automotive, aerospace and defense, data center & networks, electronics, and semiconductor & abrasives | Producer Manufacturing |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
Gilboa Therapeutics Ltd.
Gilboa Therapeutics Ltd. BiotechnologyHealth Technology Develops novel cell therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Barry A. Labinger
